Key result
HOMA correlates moderately with euglycemic clamp-derived insulin sensitivity in hypertensive and normotensive individuals.
Observational (n=63)
Effect estimate: r = -0.64 in hypertensive; r = -0.58 in normotensive
p-value: p=<.0001 for hypertensive, .002 for normotensive
The homeostasis model assessment (HOMA) has been extensively used as a reliable surrogate marker for measuring insulin resistance in patients with diabetes mellitus and in normal subjects. Comparative data in another insulin resistance state, hypertension, is lacking. The goal of the present study was to obtain that information by testing the correlation of HOMA with the euglycemic hyperinsulinemic clamp in 36 hypertensive and 27 normotensive subjects. Clamp-derived insulin sensitivity was calculated as the glucose disposal rate over steady-state plasma insulin concentration. Homeostasis model assessment was computed using the formula (fasting glucose x fasting insulin)/22.5. There was significant correlation between the clamp and HOMA for both the hypertensive (r = -0.64, P < .0001) and normotensive subjects (r = -0.58, P = .002). The HOMA can be used reliably as a less expensive and less cumbersome alternative for measuring insulin resistance in hypertension.
No takes yet. Share an insight, caveat, or question.
M. Cecilia Lansang (2001) conducted an observational in Hypertension (n=63). Homeostasis model assessment (HOMA) vs. Euglycemic hyperinsulinemic clamp was evaluated on Correlation between HOMA and clamp-derived insulin sensitivity (r = -0.64 in hypertensive; r = -0.58 in normotensive, p=<.0001 for hypertensive, .002 for normotensive). The homeostasis model assessment (HOMA) significantly correlated with the euglycemic hyperinsulinemic clamp in both hypertensive (r = -0.64, P < .0001) and normotensive subjects (r = -0.58, P = .002).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: